These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 33767058)

  • 1. Complement and kidney disease, new insights.
    Medjeral-Thomas NR; Pickering MC; Cook HT
    Curr Opin Nephrol Hypertens; 2021 May; 30(3):310-316. PubMed ID: 33767058
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Gain-of-function factor H-related 5 protein impairs glomerular complement regulation resulting in kidney damage.
    Malik TH; Gitterman DP; Lavin DP; Lomax-Browne HJ; Hiemeyer EC; Moran LB; Boroviak K; Cook HT; Gilmore AC; Mandwie M; Ahmad A; Alexander IE; Logan GJ; Marchbank KJ; Bradley A; Pickering MC
    Proc Natl Acad Sci U S A; 2021 Mar; 118(13):. PubMed ID: 33753502
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Complement Factor H-Related Proteins FHR1 and FHR5 Interact With Extracellular Matrix Ligands, Reduce Factor H Regulatory Activity and Enhance Complement Activation.
    Papp A; Papp K; Uzonyi B; Cserhalmi M; Csincsi ÁI; Szabó Z; Bánlaki Z; Ermert D; Prohászka Z; Erdei A; Ferreira VP; Blom AM; Józsi M
    Front Immunol; 2022; 13():845953. PubMed ID: 35392081
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Glomerular Complement Factor H-Related Protein 5 (FHR5) Is Highly Prevalent in C3 Glomerulopathy and Associated With Renal Impairment.
    Medjeral-Thomas NR; Moffitt H; Lomax-Browne HJ; Constantinou N; Cairns T; Cook HT; Pickering MC
    Kidney Int Rep; 2019 Oct; 4(10):1387-1400. PubMed ID: 31701048
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Selective Binding of Heparin/Heparan Sulfate Oligosaccharides to Factor H and Factor H-Related Proteins: Therapeutic Potential for C3 Glomerulopathies.
    Loeven MA; Maciej-Hulme ML; Yanginlar C; Hubers MC; Kellenbach E; de Graaf M; van Kuppevelt TH; Wetzels J; Rabelink TJ; Smith RJH; van der Vlag J
    Front Immunol; 2021; 12():676662. PubMed ID: 34489931
    [TBL] [Abstract][Full Text] [Related]  

  • 6. C3 glomerulopathy-associated CFHR1 mutation alters FHR oligomerization and complement regulation.
    Tortajada A; Yébenes H; Abarrategui-Garrido C; Anter J; García-Fernández JM; Martínez-Barricarte R; Alba-Domínguez M; Malik TH; Bedoya R; Cabrera Pérez R; López Trascasa M; Pickering MC; Harris CL; Sánchez-Corral P; Llorca O; Rodríguez de Córdoba S
    J Clin Invest; 2013 Jun; 123(6):2434-46. PubMed ID: 23728178
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Complement in IgA Nephropathy: The Role of Complement in the Pathogenesis, Diagnosis, and Future Management of IgA Nephropathy.
    Medjeral-Thomas NR; O'Shaughnessy MM
    Adv Chronic Kidney Dis; 2020 Mar; 27(2):111-119. PubMed ID: 32553243
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Progressive IgA Nephropathy Is Associated With Low Circulating Mannan-Binding Lectin-Associated Serine Protease-3 (MASP-3) and Increased Glomerular Factor H-Related Protein-5 (FHR5) Deposition.
    Medjeral-Thomas NR; Troldborg A; Constantinou N; Lomax-Browne HJ; Hansen AG; Willicombe M; Pusey CD; Cook HT; Thiel S; Pickering MC
    Kidney Int Rep; 2018 Mar; 3(2):426-438. PubMed ID: 29725647
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Different Aspects of Classical Pathway Overactivation in Patients With C3 Glomerulopathy and Immune Complex-Mediated Membranoproliferative Glomerulonephritis.
    Michels MAHM; van de Kar NCAJ; van Kraaij SAW; Sarlea SA; Gracchi V; Engels FAPT; Dorresteijn EM; van der Deure J; Duineveld C; Wetzels JFM; van den Heuvel LPWJ; Volokhina EB
    Front Immunol; 2021; 12():715704. PubMed ID: 34456924
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Complement and glomerular disease: new insights.
    Pickering M; Cook HT
    Curr Opin Nephrol Hypertens; 2011 May; 20(3):271-7. PubMed ID: 21422921
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Targeting complement in IgA nephropathy.
    Caravaca-Fontán F; Gutiérrez E; Sevillano ÁM; Praga M
    Clin Kidney J; 2023 Dec; 16(Suppl 2):ii28-ii39. PubMed ID: 38053977
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Circulating complement factor H-related proteins 1 and 5 correlate with disease activity in IgA nephropathy.
    Medjeral-Thomas NR; Lomax-Browne HJ; Beckwith H; Willicombe M; McLean AG; Brookes P; Pusey CD; Falchi M; Cook HT; Pickering MC
    Kidney Int; 2017 Oct; 92(4):942-952. PubMed ID: 28673452
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prevention of Fatal C3 Glomerulopathy by Recombinant Complement Receptor of the Ig Superfamily.
    Wang X; Van Lookeren Campagne M; Katschke KJ; Gullipalli D; Miwa T; Ueda Y; Wang Y; Palmer M; Xing G; Song WC
    J Am Soc Nephrol; 2018 Aug; 29(8):2053-2059. PubMed ID: 29895552
    [No Abstract]   [Full Text] [Related]  

  • 14. Complement gene variants determine the risk of immunoglobulin-associated MPGN and C3 glomerulopathy and predict long-term renal outcome.
    Iatropoulos P; Noris M; Mele C; Piras R; Valoti E; Bresin E; Curreri M; Mondo E; Zito A; Gamba S; Bettoni S; Murer L; Fremeaux-Bacchi V; Vivarelli M; Emma F; Daina E; Remuzzi G
    Mol Immunol; 2016 Mar; 71():131-142. PubMed ID: 26895476
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Glomerular activation of the lectin pathway of complement in IgA nephropathy is associated with more severe renal disease.
    Roos A; Rastaldi MP; Calvaresi N; Oortwijn BD; Schlagwein N; van Gijlswijk-Janssen DJ; Stahl GL; Matsushita M; Fujita T; van Kooten C; Daha MR
    J Am Soc Nephrol; 2006 Jun; 17(6):1724-34. PubMed ID: 16687629
    [TBL] [Abstract][Full Text] [Related]  

  • 16. C4 Nephritic Factors in C3 Glomerulopathy: A Case Series.
    Zhang Y; Meyer NC; Fervenza FC; Lau W; Keenan A; Cara-Fuentes G; Shao D; Akber A; Fremeaux-Bacchi V; Sethi S; Nester CM; Smith RJH
    Am J Kidney Dis; 2017 Dec; 70(6):834-843. PubMed ID: 28838767
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The role of complement in IgA nephropathy.
    Tortajada A; Gutierrez E; Pickering MC; Praga Terente M; Medjeral-Thomas N
    Mol Immunol; 2019 Oct; 114():123-132. PubMed ID: 31351413
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Excretion of complement proteins and its activation marker C5b-9 in IgA nephropathy in relation to renal function.
    Onda K; Ohsawa I; Ohi H; Tamano M; Mano S; Wakabayashi M; Toki A; Horikoshi S; Fujita T; Tomino Y
    BMC Nephrol; 2011 Nov; 12():64. PubMed ID: 22111871
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Outcome of membranoproliferative glomerulonephritis and C3-glomerulopathy in children and adolescents.
    Holle J; Berenberg-Goßler L; Wu K; Beringer O; Kropp F; Müller D; Thumfart J
    Pediatr Nephrol; 2018 Dec; 33(12):2289-2298. PubMed ID: 30238151
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Complement in glomerular diseases.
    Tan Y; Zhao MH
    Nephrology (Carlton); 2018 Oct; 23 Suppl 4():11-15. PubMed ID: 30298653
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.